Biotech · Private company · San Diego, CA, US
Ting Therapeutics, Inc.
Track this companyFree. Adds Ting Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards8
- Therapeutics to prevent aminoglycoside-induced hearing lossFiscal year 2026 · $524.3KNIH RePORTER 5R44DC019065-05 · fetched Nov 12, 2026
- Therapeutics to prevent aminoglycoside-induced hearing lossFiscal year 2025 · $524.3KNIH RePORTER 5R44DC019065-04 · fetched Nov 12, 2026
- Therapeutics to prevent aminoglycoside-induced hearing lossFiscal year 2024 · $1NIH RePORTER 2R44DC019065-02A1 · fetched Nov 12, 2026
- CDK2 inhibitors for protecting hearing lossFiscal year 2024 · $176.8KNIH RePORTER 5R44DC018463-04 · fetched Nov 12, 2026
- Preclinical evaluation of an otoprotectant TT002Fiscal year 2024 · $1NIH RePORTER 5R44DC018762-04 · fetched Nov 12, 2026
- CDK2 inhibitors for protecting hearing lossFiscal year 2024 · $174.7KNIH RePORTER 6R44DC018463-05 · fetched Nov 12, 2026
- Preclinical evaluation of an otoprotectant TT002Fiscal year 2024 · $326.4KNIH RePORTER 6R44DC018762-05 · fetched Nov 12, 2026
- Therapeutics to prevent aminoglycoside-induced hearing lossFiscal year 2024 · $524.3KNIH RePORTER 6R44DC019065-03 · fetched Nov 12, 2026